PRIMARY IMMUNE THROMBOCYTOPENIA
Clinical trials for PRIMARY IMMUNE THROMBOCYTOPENIA explained in plain language.
Never miss a new study
Get alerted when new PRIMARY IMMUNE THROMBOCYTOPENIA trials appear
Sign up with your email to follow new studies for PRIMARY IMMUNE THROMBOCYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for Long-Term platelet control in rare bleeding disorder
Disease control CompletedThis study tested a drug called efgartigimod in 101 adults with primary immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding risks. The goal was to see if the drug is safe and helps maintain healthy platelet levels over a year. P…
Matched conditions: PRIMARY IMMUNE THROMBOCYTOPENIA
Phase: PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated May 17, 2026 02:15 UTC
-
ITP Patients' brain fog and fatigue under the microscope
Knowledge-focused CompletedThis study looked at how chronic immune thrombocytopenia (ITP) affects thinking skills and fatigue in adults. Researchers measured cognitive function and inflammation markers in 97 patients using blood tests and computer-based assessments. The goal was to better understand the li…
Matched conditions: PRIMARY IMMUNE THROMBOCYTOPENIA
Sponsor: Sanofi • Aim: Knowledge-focused
Last updated May 17, 2026 02:14 UTC